The company is trading for roughly the cash on its balance sheet. The RGX-121 program is presently the furthest in development. REGENXBIO is pushing ahead with partner Nippon Shinyaku to ...

That said, the streaming service does still occasionally add a long-running series, as was the case with Younger this month. Based on Pamela Redmond Satran’s 2005 novel of the same, Younger is a ...

Regenxbio Inc. remains undervalued despite its cutting-edge AAV gene therapy technology and promising assets like RGX-314 for wet AMD and RGX-121 for MPS II. RGX-314, partnered with AbbVie ...

Dust off your spandex, crimp your hair, and don your best neon gear ready for a retro rave. Celebrating four decades of the celebrated compilation albums, Now That's What I Call A Musical is ...

To be totally honest, it’s nigh on impossible to select the best electric guitar. Guitars come in such a variety of styles and configurations that finding a single instrument in such a crowded ...

Choosing the best acoustic guitar for your personal needs is a tough one. With so many options on offer these days it’s not surprising that many find themselves faced with option paralysis when ...

14, 2025, ahead of the pre-sale exhibition at Christies auction rooms in London. (AP Photo/Kirsty Wigglesworth) An art handler displays a Duesenburg, Hanover, Germany, 2019, a semi solid-body electric ...

That partner, Japan’s Nippon Shinyaku, is handing over $110 million upfront to lead on the commercialization of two gene therapies—RGX-121 for Hunter syndrome and RGX-111 for Hurler syndrome.

(RTTNews) - REGENXBIO Inc. (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II ...

Some of the most iconic guitars in rock history are going on display in London before they go under the hammer at auction LONDON -- Some of the most iconic guitars in rock history are going on ...

Ltd. (Nippon Shinyaku) today announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II (MPS II), also known as Hunter ...